HIV Protease Inhibitors Cure Lupus-Prone Mice and Prevent T Helper 17 Cell-Driven Inflammation By Inhibiting CD95-Non-Apoptotic Signaling Pathway

Manon Charrier (1) , Amanda Poissonnier (2) , Daniel Best (2) , Jean-Philippe Guégan (2) , Nicolas Levoin (3) , Raphael Pineau (2) , Florence Jouan (2) , Ha Thanh Nguyen , Lucie Morere (2) , Sophie Martin (2) , Melissa Thomas (2) , Estibaliz Lazaro (1) , Christophe Richez (1) , Isabelle Douchet (1) , Thomas Ducret (4) , Pierre van de Weghe (2) , Patrick Blanco (1) , Mickael Jean (2) , Pierre Vacher (4) , Patrick Legembre (2)

1 CIRID - Composantes innées de la réponse immunitaire et différenciation
2 COSS - Chemistry, Oncogenesis, Stress and Signaling
3 Bioprojet-Biotech
4 ACTION - Actions for OnCogenesis understanding and Target Identification in ONcology

Domains: Life Sciences [q-bio]; Cancer

Manon Charrier, Amanda Poissonnier, Daniel Best, Jean-Philippe Guégan, Nicolas Levoin, et al.. HIV Protease Inhibitors Cure Lupus-Prone Mice and Prevent T Helper 17 Cell-Driven Inflammation By Inhibiting CD95-Non-Apoptotic Signaling Pathway. Arthritis & rheumatology, 2018, 70 (suppl 10). ⟨hal-01940201⟩